| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CFO And Secretary | CFO, Chief Bus. Off. And Secy. | Chief Business Officer
2 companies
Levy Adam Scott is a Chief Business Officer at Viridian Therapeutics, Inc.\DE with holdings across 2 companies. Recent SEC Form 4 filings include 3 buys and 0 sells.
Estimated insider holdings value: $430K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 14, 2023 | MLYS Mineralys Therapeutics, Inc. | CFO, Chief Bus. Off. And Secy. | Buy | 6,250 | $16.00 | $100,000.00 | +1.8% | -10.1% | -19.3% | |
| Feb 13, 2018 | VRDN Viridian Therapeutics, Inc.\de | Chief Business Officer | Buy | 9,090 | $5.50 | $49,995.00 | +626.9% | - | - | |
| Jun 22, 2017 | VRDN Viridian Therapeutics, Inc.\de | Chief Business Officer | Buy | 200 | $7.55 | $1,510.00 | New | - | - |